capecitabine has been researched along with Sexual Dysfunction, Physiological in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Al-Najami, I; Cunningham, C; Jones, HJS | 1 |
He, X; Li, K; Tong, S; Zheng, Y | 1 |
2 other study(ies) available for capecitabine and Sexual Dysfunction, Physiological
Article | Year |
---|---|
Quality of life after rectal-preserving treatment of rectal cancer.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Defecation; Dyspareunia; Erectile Dysfunction; Fecal Incontinence; Female; Gastrointestinal Hemorrhage; Humans; Lower Urinary Tract Symptoms; Male; Neoadjuvant Therapy; Organ Sparing Treatments; Proctectomy; Quality of Life; Rectal Neoplasms; Sexual Dysfunction, Physiological; Watchful Waiting | 2020 |
Risk factors for sexual dysfunction after rectal cancer surgery in 948 consecutive patients: A prospective cohort study.
Topics: Adenocarcinoma; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Digestive System Surgical Procedures; Female; Fluorouracil; Humans; Leucovorin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Postoperative Complications; Proctectomy; Prospective Studies; Radiotherapy; Rectal Neoplasms; Risk Factors; Sexual Dysfunction, Physiological | 2021 |